Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V

被引:44
作者
Biagi, G
Giorgi, I
Livi, O
Nardi, A
Calderone, V
Martelli, A
Martinotti, E
Salerni, OL
机构
[1] Univ Pisa, Dipartimento Sci Farmaceut, I-56126 Pisa, Italy
[2] Univ Pisa, Dipartimento Psichiat Neurobiol Farmacol & Biotec, I-56126 Pisa, Italy
[3] Butler Univ, Coll Pharm & Hlth Sci, Indianapolis, IN 46208 USA
关键词
benzanilides; BK channels; BK-openers; vasodilator activity;
D O I
10.1016/j.ejmech.2004.02.006
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
As part of our program toward designing potassium channel openers, the synthesis of a novel series of substituted benzanilides and their vasodilating activity are presented. The facile synthetic pathway generally involves coupling between the appropriate benzoyl chloride and commercial available anilines, followed by the selective or non-selective cleavage of methyl ether substituent(s), affording the corresponding phenol or bisphenol derivatives. The pharmacological evaluation of these structurally novel potential BK-openers on vascular contractile activity was studied in vitro, using isolated rat aortic rings pre-contracted with KCl 20 mM. Some derivatives were found to be potent smooth muscle relaxants and the vasodilation effects of these compounds were inhibited by tetraethyl ammonium (TEA) and iberiotoxin (IbTX), suggesting that the opening of BK channels is prevalent in the mechanism of action of these compounds. The best compound of the series was N-(2-hydroxy-5-phenyl)-(2-methoxy-5-chloro)-benzamide (16b) showing a full vasorelaxant efficacy and almost nanomolar potency index. (C) 2004 Elsevier SAS. All rights reserved.
引用
收藏
页码:491 / 498
页数:8
相关论文
共 35 条
[1]   Triazolyl-benzimidazolones and triazolyl-benzotriazoles: new potential potassium channel activators. II [J].
Baragatti, B ;
Biagi, G ;
Calderone, V ;
Giorgi, I ;
Livi, O ;
Martinotti, E ;
Scartoni, V .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (10) :949-955
[2]  
Berger MG, 1999, PERSPECT DRUG DISCOV, V16, P313
[3]   Some structural changes on triazolyl-benzotriazoles and triazolyl-benzimidazolones as potential potassium channel activators. III [J].
Biagi, G ;
Calderone, V ;
Giorgi, I ;
Livi, O ;
Scartoni, V ;
Baragatti, B ;
Martinotti, E .
FARMACO, 2001, 56 (11) :841-849
[4]   New 5-substituted-1-(2-hydroxybenzoyl)-benzotriazoles, potassium channel activators. IV [J].
Biagi, G ;
Giorgi, I ;
Livi, O ;
Scartoni, V ;
Barili, PL ;
Calderone, V ;
Martinotti, E .
FARMACO, 2001, 56 (11) :827-834
[5]   5-(4′-substituted-2′-nitroanilino)-1,2,3-triazoles as new potential potassium channel activators.: I [J].
Biagi, G ;
Calderone, V ;
Griorgi, I ;
Livi, O ;
Scartoni, V ;
Baragatti, B ;
Martinotti, E .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (7-8) :715-720
[6]  
BLUM J, 1991, Patent No. 2658192
[8]   Recent developments in the biology and medicinal chemistry of potassium channel modulators: Update from a decade of progress [J].
Coghlan, MJ ;
Carroll, WA ;
Gopalakrishnan, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (11) :1627-1653
[9]  
DEAN FM, 1966, TETRAHEDRON LETT, P4153
[10]   COLOCALIZATION OF ACTIVE KCA CHANNELS AND CA2+ CHANNELS WITHIN CA2+ DOMAINS IN HELIX NEURONS [J].
GOLA, M ;
CREST, M .
NEURON, 1993, 10 (04) :689-699